Akebia Therapeutics, Inc. (AKBA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.1500 |
| Open | 1.1400 |
| Bid | 1.1200 x 900 |
| Ask | 1.1700 x 1600 |
| Day's Range | 1.1200 - 1.2000 |
| 52 Week Range | 0.7800 - 2.4800 |
| Volume | |
| Avg. Volume | 5,207,490 |
| Market Cap | 241.035M |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2200 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
PR NewswireAkebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the 2nd Annual HCW Bioconnect Investor Conference on Monday, May 20th, 2024 at 3:00 p.m. ET.
Simply Wall St.Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
The analysts covering Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) delivered a dose of negativity to shareholders today...
GuruFocus.comAkebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Insights into Akebia Therapeutics' Performance and Strategic Developments
© 2024 Yahoo. All rights reserved.